Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Betamethasone valerate 2.25mg medicated plasters
1304000F0AADWDW
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 458 |
|
Salicylic acid 2% ointment
1305020S0AAABAB
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 457 |
|
Silver nitrate 95% caustic pencils
1307000Q0AAAAAA
|
Silver nitrate | Silver nitrate | Skin | 451 |
|
Synalar C ointment
1304000N0BBAMCC
|
Synalar | Fluocinolone acetonide | Skin | 442 |
|
Salicylic acid 40% medicated plasters
1307000M0AABSBS
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 423 |
|
Fluocinolone acetonide 0.00625% cream
1304000N0AAADAD
|
Fluocinolone acetonide | Fluocinolone acetonide | Skin | 422 |
|
Menthoderm 5% cream
1303000AABFADAF
|
Menthoderm | Menthol | Skin | 421 |
|
Synalar C cream
1304000N0BBAKCA
|
Synalar | Fluocinolone acetonide | Skin | 403 |
|
Roaccutane 20mg capsules
1306020J0BBABAB
|
Roaccutane | Isotretinoin | Skin | 402 |
|
Fludroxycortide 0.0125% cream
1304000T0AAAAAA
|
Fludroxycortide | Fludroxycortide | Skin | 398 |
|
Canesten Hydrocortisone cream
1304000V0CHACCI
|
Canesten (hydrocortisone) | Hydrocortisone | Skin | 394 |
|
Liquid paraffin light 82.8% bath additive
1302011L0AAAEAE
|
Light liquid paraffin | Light liquid paraffin | Skin | 386 |
|
Soya oil 82.95% / Lauromacrogols 15% bath oil
130201100AAAGAG
|
Generic compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | 381 |
|
Fucibet Lipid cream
1304000F0BCACCC
|
Fucibet | Betamethasone valerate | Skin | 380 |
|
Surgical spirit
1311010A0AAABAB
|
Industrial methylated spirit | Alcohol | Skin | 379 |
|
Duofilm paint
1307000M0BKABBY
|
Duofilm | Salicylic acid | Skin | 372 |
|
Clindamycin 1% alcoholic solution
1306010F0AAAAAA
|
Clindamycin phosphate (Topical) | Clindamycin phosphate | Skin | 362 |
|
Hedrin 4% lotion
1310040V0BBAAAA
|
Hedrin | Dimeticone (Parasiticidal) | Skin | 362 |
|
Nicotinamide 4% gel
1306010N0AAAAAA
|
Nicotinamide (Topical) | Nicotinamide | Skin | 354 |
|
Cutivate 0.005% ointment
1304000S0BBABAB
|
Cutivate | Fluticasone propionate (Topical) | Skin | 347 |
|
Terbinafine 1% solution
131002030AAADAD
|
Terbinafine hydrochloride (Topical) | Terbinafine hydrochloride | Skin | 333 |
|
Eczmol 1% cream
1302010Z0BBAAAA
|
Eczmol | Chlohexidine gluconate (Emollient) | Skin | 323 |
|
Eucerin DermoCapillaire Calming urea scalp treatment
1302010U0BGAJAW
|
Eucerin | Urea | Skin | 321 |
|
Exorex moisturising cream
130502000BBBDA0
|
Proprietary compound preparation BNF 1305020 | Other psoriasis preparations | Skin | 321 |
|
Keromask finishing powder
130802000BBBBAA
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | 319 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.